Trial Profile
Comparison of Apidra [insulin glulisine] to regular insulin in hospitalized patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin; Insulin glargine
- Indications Hyperglycaemia; Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 27 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Aug 2010 Planned end date changed from May 2009 to May 2011 as reported by ClinicalTrials.gov.
- 16 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.